PD-1+memory phenotype CD4+T cells expressing C/EBPα underlie T cell immunodepression in senescence and leukemia
CD4-Positive T-Lymphocytes
Mice, Knockout
0301 basic medicine
570
Aging
Leukemia, Experimental
Programmed Cell Death 1 Receptor
610
DNA-Binding Proteins
Mice, Inbred C57BL
Mice
03 medical and health sciences
Phenotype
Antigens, Surface
CCAAT-Enhancer-Binding Protein-alpha
Immune Tolerance
Animals
Osteopontin
Apoptosis Regulatory Proteins
Immunologic Memory
Cell Proliferation
DOI:
10.1073/pnas.0908805106
Publication Date:
2009-09-09T02:20:39Z
AUTHORS (5)
ABSTRACT
Although altered T cell function plays a part in immunosenescence, the mechanisms remain uncertain. Here we identify a bona fide age-dependent PD-1+memory phenotype (MP) CD4+T cell subpopulation that hardly proliferates in response to T cell receptor (TCR) stimulation and produces abundant osteopontin at the cost of typical T cell lymphokines. These T cells demonstrate impaired repopulation in Rag2−/−mice, but a homeostatic proliferation in γ-ray–irradiated mice. These T cells also reveal a unique molecular signature, including a strong expression of C/EBPα normally expressed in myeloid-lineage cells, with diminished c-Myc and cyclin D1. Transduction ofCebpain regular CD4+T cells inhibited the TCR-mediated proliferation withc-Mycandcyclin D1repression and caused a striking activation ofSpp1encoding osteopontin along with concomitant repression of T cell lymphokine genes. Although these T cells gradually increase in number with age and become predominant at the senescent stage in normal mice, the generation is robustly accelerated during leukemia. In both conditions, their predominance is associated with the diminution of specific CD4+T cell response. The results suggest that global T cell immunodepression in senescence and leukemia is attributable to the increase in PD-1+MP CD4+T cells expressing C/EBPα.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (118)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....